GLP-1 receptor agonists have demonstrated glycaemic control, cardiovascular benefits in certain patient populations and significant weight reduction effects
Differential effect of polysaccharide and nonpolysaccharide components in sijunzi decoction on spleen deficiency syndrome and their mechanisms
Proc Natl Acad Sci U S A , 109 (38), 1510115108
This delayed gastric emptying creates a prolonged sense of satiety that reduces overall food intake without the stimulant-driven appetite suppression that phentermine relies on
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context on metabolic efficiency and antioxidant pathway function through analysis of genetic predispositions in FTO, MC4R, and metabolic-related variants
Who Should Evaluate GLP-1 Use in Hashimoto's and What to Discuss Patients with Hashimoto's who are candidates for GLP-1 therapy must have separate clinical indication (obesity, type 2 diabetes, cardiovascular risk) and stable thyroid disease controlled on levothyroxine
